Rebiopsy for Patients with Non-Small Cell Lung Cancer after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Failure

被引:0
|
作者
Li, Xuefei [1 ]
Su, Chunxia [2 ]
Ren, Shengxiang [2 ]
Zhao, Chao [1 ]
Jiang, Tao [1 ]
Zhou, Caicun [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China
关键词
rebiopsy; non-small cell lung cancer; EGFR-TKI; EGFR mutation;
D O I
10.1016/j.jtho.2016.11.1772
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.02b-104
引用
收藏
页码:S1256 / S1256
页数:1
相关论文
共 50 条
  • [1] Feasibility of Rebiopsy in Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
    Hasegawa, Takaaki
    Sawa, Toshiyuki
    Futamura, Yohei
    Horiba, Akane
    Ishiguro, Takashi
    Marui, Tsutomu
    Yoshida, Tsutomu
    [J]. INTERNAL MEDICINE, 2015, 54 (16) : 1977 - 1980
  • [2] Rebiopsy for patients with non-small-cell lung cancer after epidermal growth factor receptor-tyrosine kinase inhibitor failure
    Kawamura, Takahisa
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Nakajima, Takashi
    Ohde, Yasuhisa
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. CANCER SCIENCE, 2016, 107 (07) : 1001 - 1005
  • [3] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [4] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [5] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    [J]. CANCER, 2013, 119 (24) : 4325 - 4332
  • [6] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [7] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    [J]. Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [8] Epidermal growth factor receptor tyrosine kinase inhibitors - Application in non-small cell lung cancer
    Thomas, M
    [J]. CANCER NURSING, 2003, 26 (06) : 21S - 25S
  • [9] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [10] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Malik, Prabhat Singh
    Jain, Deepali
    Kumar, Lalit
    [J]. ONCOLOGY, 2016, 91 : 26 - 34